|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 97, 267-274, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
H Otani, RM Engelman, JA Rousou, RH Breyer, R Clement, R Prasad, J Klar and DK Das
Activation of an intracellular calcium-calmodulin complex may play an
important role in myocardial injury induced by ischemia and reperfusion.
Trifluoperazine, a calmodulin antagonist, was used before ischemia to
enhance myocardial preservation by preventing intracellular calcium
accumulation. The experimental model used an isolated in situ pig heart (19
control animals and 15 trifluoperazine-treated animals) subjected to
occlusion of the left anterior descending coronary artery for 60 minutes
followed by 60 minutes of hypothermic potassium crystalloid cardioplegic
arrest and 60 minutes of reperfusion. Myocardial segmental function
measured by ultrasonic crystals showed that active systolic segment
shortening was abolished in the distribution of the left anterior
descending artery after 60 minutes of occlusion irrespective of the
treatment, whereas that not in the distribution of the left anterior
descending artery increased by about 15% in both groups of animals.
Restoration of systolic segment shortening in the distribution of the left
anterior descending artery 60 minutes after reperfusion was 12% and 42% of
baseline levels in untreated and trifluoperazine-treated animals,
respectively (p less than 0.01). This improvement in segmental function by
trifluoperazine was reflected in significantly (p less than 0.05) better
global myocardial contractility and compliance and in significantly (p less
than 0.01) greater total coronary blood flow and myocardial oxygen
consumption. Trifluoperazine also increased myocardial creatine phosphate
content in the distribution of the left anterior descending artery (p less
than 0.01) during reperfusion, and creatine kinase release was reduced (p
less than 0.05). Our results suggest that trifluoperazine improved regional
myocardial function after acute occlusion of the left anterior descending
artery and reperfusion and that global cardiac performance was thereby
improved. The beneficial effects of trifluoperazine may be exerted by
prevention of myocardial injury associated with the calcium-calmodulin
complex in ischemic and reperfused myocardium.
ARTICLES
Improvement of myocardial function by trifluoperazine, a calmodulin antagonist, after acute coronary artery occlusion and coronary revascularization
Department of Surgery, University of Connecticut School of Medicine, Farmington.
This article has been cited by other articles:
![]() |
D. K. Das, R. M. Engelman, N. Maulik, J. A. Rousou, J. E. Flack III, and D. W. Deaton Molecular targets of gene therapy Ann. Thorac. Surg., November 1, 1999; 68(5): 1929 - 1933. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Hampton, I. Amende, K. E. Travers, and J. P. Morgan Intracellular calcium dynamics in mouse model of myocardial stunning Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1821 - H1827. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kuroda, A. Nakai, T. Kristian, and B. K. Siesjo The Calmodulin Antagonist Trifluoperazine in Transient Focal Brain Ischemia in Rats : Anti-ischemic Effect and Therapeutic Window Stroke, December 1, 1997; 28(12): 2539 - 2544. [Abstract] [Full Text] |
||||
![]() |
N. Maulik, R. M. Engelman, Z. Wei, X. Liu, J. A. Rousou, J. E. Flack, D. W. Deaton, and D. K. Das Drug-Induced Heat-Shock Preconditioning Improves Postischemic Ventricular Recovery After Cardiopulmonary Bypass Circulation, November 1, 1995; 92(9): 381 - 388. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |